Pinghan Wang
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The bench-to-bedside journey of circular RNAs in cancer: Status, challenges and future prospects.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: May 07, 2026
Kaempferol targets Src to exert its chemopreventive effects on mammary tumorigenesis via regulation of the PI3K/AKT pathway.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: September 20, 2024
Col1A1 as a new decoder of clinical features and immune microenvironment in ovarian cancer.
Journal: Frontiers in immunology
Published: September 16, 2024
Chemopreventive effects of atractylenolide-III on mammary tumorigenesis via activation of the Nrf2/ARE pathway through autophagic degradation of Keap1.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 08, 2024
The role of circular RNAs in regulating resistance to cancer immunotherapy: mechanisms and implications.
Journal: Cell death & disease
Published: February 16, 2024
Deciphering the impact of circRNA-mediated autophagy on tumor therapeutic resistance: a novel perspective.
Journal: Cellular & molecular biology letters
Published: January 03, 2024
Wogonin Diminishes Radioresistance of Breast Cancer via Inhibition of the Nrf2/HIF-1[Formula: see text] Pathway.
Journal: The American journal of Chinese medicine
Published: October 30, 2023
Upregulation of circ_0008812 and circ_0001583 predicts poor prognosis and promotes breast cancer proliferation.
Journal: Frontiers in molecular biosciences
Published: August 11, 2022
Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance.
Journal: Molecular cancer
Published: May 26, 2022
Dietary phytochemicals targeting Nrf2 for chemoprevention in breast cancer.
Journal: Food & function
Published: April 04, 2022
Dietary Phytochemicals Targeting Nrf2 to Enhance the Radiosensitivity of Cancer.
Journal: Oxidative medicine and cellular longevity
Published: January 07, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026